Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Cell. 2016 Jun 30;166(1):1. doi: 10.1016/j.cell.2016.06.036.
Denvaxia is the first licensed vaccine for the prevention of dengue. It is a live vaccine developed using recombinant DNA technology. The vaccine is given as three doses over the course of a year and has the potential to prevent hundreds of thousands of hospitalizations each year.
登革热疫苗是全球首款获准上市的登革热预防疫苗，属于使用重组 DNA 技术研发的减毒活疫苗。该疫苗需在一年内分 3 次接种，每年有望预防数十万人住院。
